Roblon (One-pager): Guidance maintained after Q1 2023/24 despite weaker FOC demand
Roblon
WindowMaster (One-pager): 2024 momentum confirmed by upward adjustment of guidance range
WindowMaster International
Asetek (One-pager): SimSports scale up to continue in 2024
Asetek
Curasight (one-pager): Halving of market implied likelihood of succes looks exaggerated
Curasight
Aktier i Vælten – Ambu: Alle taler værdisætning
Ambu
ViserViser Alle regioner, Alle indholdstyper
Share starts trading without unit rights and warrants
Purmo's peer sold at a good price
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Scanfil Q1 on Wednesday: Year-on-year decline likely, but fairly solid figures can be expected
Innofactor Q1 on Tuesday: Satisfactory quarter by the company's standards expected, still outperforming the sector
Anora AGM | CEO's review 17.4.2024
Dagens aktienyheder 17/04: Gubra Netcompany, Scandinavian Medical Solutions, ExpreS2ion Biotechnologies og Curasight
Market rumor: Saxo Bank is considering strategic options
Purmo Q1 next Wednesday: Further decline expected, improvement for the year as a whole
Enento Q1 next Tuesday: Clear backpedaling in figures still expected
Nightingale opens its own laboratory in the US and wins a new customer
Expres2ion Biotechnologies: Completes GLP safety study for ES2B-C001 (HER2-VLP) breast cancer vaccine candidate
Inderes' AGM | Board of Directors Q&A
GreenMobility: Strategy change showing effect in Q1 2024
Roblon (One-pager): Guidance maintained after Q1 2023/24 despite weaker FOC demand
Dagens aktienyheder 16/04: WindowMaster og Curasight
Mendus: Changing the course of cancer treatment
Looming threats to the bull market
Curasight (one-pager): Halving of market implied likelihood of succes looks exaggerated
WindowMaster (One-pager): 2024 momentum confirmed by upward adjustment of guidance range
Kommende selskabspræsentationer
Seneste analyser
Share starts trading without unit rights and warrants
Reducer
Scibase Holding
18.04.2024
Roblon (One-pager): Guidance maintained after Q1 2023/24 despite weaker FOC demand
Roblon
16.04.2024
Curasight (one-pager): Halving of market implied likelihood of succes looks exaggerated
Curasight
16.04.2024
WindowMaster (One-pager): 2024 momentum confirmed by upward adjustment of guidance range
WindowMaster International
16.04.2024
Koskisen: A pause for breath as the major undervaluation has dissipated
Reducer
Koskisen
12.04.2024